Table 1.

Demographics and diagnoses of patients treated on study.

Demographics	Part C	Part D	Part E	Total
	Number (%)	Number (%)	Number (%)	Number (%)
	N=18	N=29	N=8	N=55
Age (years)
Median Range	14 4–17	17 5–27	19 11–28	15 4–28
Sex
Male Female	10 (56) 8 (44)	21 (72) 8 (28)	3 (38) 5 (62)	34 (62) 21 (38)
Race
White Asian American Indian or Alaska Native Black or African American Unknown	11 (61) 2 (11) 1 (6) 2 (11) 2 (11)	23 (79) 0 (0) 0 (0) 2 (7) 4 (14)	8 (100) 0 (0) 0 (0) 0 (0) 0 (0)	42 (76) 2 (4) 1 (2) 4 (7) 6 (11)
Ethnicity
Non-Hispanic Hispanic Unknown	15 (83) 3 (17) 0 (0)	22 (76) 5 (17) 2 (7)	5 (62) 1 (13) 2 (25)	42 (76) 9 (16) 4 (7)
Prior Therapy
Chemotherapy Regimens Median Range	2.5 1–8	3 1–7	2.5 1–5	3 1–8
Radiation Therapy Cycles Median Range	2 1–4	1 1–3	1 1–2	1 1–4
Diagnosis
Adrenal cortical adenoma, NOS	1 (5.6)			1 (1.8)
Alveolar rhabdomyosarcoma		5 (17.2)	2 (25)	7 (12.7)
Carcinoma, NOS	1 (5.6)			1 (1.8)
Desmoplastic small round cell tumor	2 (11.1)			2 (3.6)
Embryonal rhabdomyosarcoma, NOS		2 (6.9)	2 (25)	4 (7.3)
Ewing sarcoma	2 (11.1)	9 (31)	3 (37.5)	14 (25.5)
Hepatoblastoma	1 (5.6)			1 (1.8)
Myofibroblastic tumor, NOS	1 (5.6)			1 (1.8)
Myxoid liposarcoma	1 (5.6)			1 (1.8)
Nephroblastoma, NOS	2 (11.1)			2 (3.6)
Neuroblastoma, NOS	1 (5.6)			1 (1.8)
Osteosarcoma, NOS	3 (16.7)	10 (34.5)		13 (23.6)
Renal cell carcinoma, NOS	1 (5.6)			1 (1.8)
Rhabdomyosarcoma, NOS		2 (6.9)	1 (12.5)	3 (5.5)
Spindle cell rhabdomyosarcoma		1 (3.4)		1 (1.8)
Synovial sarcoma, NOS	1 (5.6)			1 (1.8)
Yolk sac tumor	1 (5.6)			1 (1.8)